In addition, all these studies conclude that blocking inhibitory PD-L1 upregulated by Ab–cytokine treatment may further improve the antitumor effect via recruiting more Ab–cytokine molecules and open new avenues for future clinical cancer treatment. Here, CD274 is linked to cancer.